1. Guidance for industry. Developing medical imaging drugs and biological products. Part 3: design, analysis, and interpretation of clinical studies (2004). URL
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071604.pdf
. Cited 21 May 2012
2. Appendix 1 to the guideline on clinical evaluation of diagnostic agents (CPMP/EWP/1119/98 REV. 1) on imaging agents (Doc. Ref. EMEA/CHMP/EWP/321180/2008) (2009). URL
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003581.pdf
. Cited 21 May 2012
3. Durkalski, V., Palesch, Y., Lipsitz, S., Rust, P.: Analysis of clustered matched-pair data for a non-inferiority study design. Statistics in Medicine
22, 279–290 (2003). DOI 10.1002/sim.1385
4. Jäger, H., Mansmann, U., Hausmann, O., Partzsch, U., Moseley, I., Taylor, W.: MRA versus digital subtraction angiography in acute subarachnoid haemorrhage: a blinded multireader study of prospectively recruited patients. Neuroradiology
42, 313–326 (2000)
5. Jin, H., Lu, Y.: Comparison of correlated proportions based on paired binary data from clustered samples. Journal of Statistical Planning and Inference
139, 4206–4212 (2009). DOI 10.1016/j.jspi.2009.06.005